Screener
Medpace Holdings, Inc. MEDP Other — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001668397-26-000025
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Therapeutic Area | ||||
| Metabolic | $219,067 | $147,873 | $456,625 | $295,888 |
| Oncology | 209,372 | 188,558 | 410,611 | 359,034 |
| Other | 98,279 | 118,062 | 191,597 | 213,898 |
| Central Nervous System | 82,858 | 61,129 | 163,065 | 116,030 |
| Cardiology | 59,982 | 58,584 | 116,243 | 116,863 |
| AVAI | 37,773 | 29,105 | 75,794 | 60,168 |
| Total revenue | $707,331 | $603,311 | $1,413,935 | $1,161,881 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Medpace Holdings, Inc.'s other — total revenue?
- Medpace Holdings, Inc. (MEDP) reported other — total revenue of $219.07M in Q2 2026.
- How has Medpace Holdings, Inc.'s other — total revenue changed year-over-year?
- Medpace Holdings, Inc.'s other — total revenue increased by 48.1% year-over-year, from $147.87M to $219.07M.
- What is the long-term trend for Medpace Holdings, Inc.'s other — total revenue?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s other — total revenue has grown at a 46.9% compound annual growth rate (CAGR), from $159.9M to $744.96M.
- What does other — total revenue mean?
- This metric represents the total gross income generated specifically from clinical research and development services provided to clients within the oncology therapeutic area. It captures the aggregate value of full-service drug development, clinical trial management, and ancillary laboratory support dedicated to cancer-related medical research. This figure serves as a primary indicator of the company's market penetration and demand for specialized expertise in the oncology sector.
Ask your AI about Medpace Holdings, Inc.'s other — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude